Chihara D, Ito H, Matsuda T et al (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164(4):536–545

Article  PubMed  Google Scholar 

Sun J, Yang Q, Lu Z et al. (2012) Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol 138 (3):429–434

Vose J, Armitage J, Weisenburger D, International TCLP (2008) International peripheral T‑cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124–4130

Article  PubMed  Google Scholar 

William BM, Armitage JO (2013) International analysis of the frequency and outcomes of NK/T-cell lymphomas. Best Pract Res Clin Haematol 26(1):23–32

Article  CAS  PubMed  Google Scholar 

Au WY, Weisenburger DD, Intragumtornchai T et al (2009) Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T‑Cell Lymphoma Project. Blood 113(17):3931–3937

Article  CAS  PubMed  Google Scholar 

Lim ST, Hee SW, Quek R et al (2008) Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T‑cell lymphoma: significant differences in clinical characteristics and prognosis. Eur J Haematol 80(1):55–60

Article  PubMed  Google Scholar 

Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wirth A, Mikhaeel NG, Aleman BMP et al (2020) Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines. Int J Radiat Oncol Biol Phys 107(5):909–933

Article  PubMed  Google Scholar 

Li YX, Coucke PA, Li JY et al. (1998) Primary non-Hodgkin’s lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 83 (3):449–456.

Au WY, Pang A, Choy C et al (2004) Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 104(1):243–249

Article  CAS  PubMed  Google Scholar 

Ito Y, Kimura H, Maeda Y et al (2012) Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type. Clin Cancer Res 18(15):4183–4190

Article  CAS  PubMed  Google Scholar 

Suzuki R, Yamaguchi M, Izutsu K et al (2011) Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type. Blood 118(23):6018–6022

Article  CAS  PubMed  Google Scholar 

Wei W, Wu P, Li L, Zhang ZH (2017) Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma. Hematology 22(6):320–329

Article  CAS  PubMed  Google Scholar 

Zhao Q, Fan S, Chang Y et al (2019) Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III–IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus. Cancer Manag Res 11:3555–3564

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu ZL, Bi XW, Liu PP et al (2018) The Clinical Utility of Circulating Epstein-Barr Virus DNA Concentrations in NK/T-Cell Lymphoma: A Meta-Analysis. Dis Markers 2018:1961058

Article  PubMed  PubMed Central  Google Scholar 

Kim SJ, Yoon DH, Jaccard A et al (2016) A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol 17(3):389–400

Article  CAS  PubMed  Google Scholar 

Kim SJ, Choi JY, Hyun SH et al (2015) Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. Lancet Haematol 2(2):e66–74

Article  PubMed  Google Scholar 

Wang L, Wang H, Wang JH et al (2015) Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase. Oncotarget 6(30):30317–30326

Article  PubMed  PubMed Central  Google Scholar 

Suh C, Kang YK, Roh JL et al (2008) Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck. J Nucl Med 49(11):1783–1789

Article  PubMed  Google Scholar 

Jiang C, Zhang X, Jiang M et al. (2015) Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type. Ann Nucl Med 29 (5):442–451.

Chang Y, Fu X, Sun Z et al (2017) Utility of baseline, interim and end-of. treatment 1(8) (F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L‑asparaginase/pegaspargase. Sci Rep 7:41057)

Deng XW, Wu JX, Wu T et al (2018) Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG). Radiother Oncol 129(1):3–9

Article  PubMed  Google Scholar 

Yang Y, Cao JZ, Lan SM et al (2017) Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma. JAMA Oncol 3(1):83–91

Article  PubMed  Google Scholar 

You JY, Chi KH, Yang MH et al (2004) Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol 15(4):618–625

Article  PubMed  Google Scholar 

Huang MJ, Jiang Y, Liu WP et al (2008) Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 70(1):166–174

Article  PubMed  Google Scholar 

Sakata K, Fuwa N, Kodaira T et al (2006) Analyses of dose-response in radiotherapy for patients with mature T/NK-cell lymphomas according to the WHO classification. Radiother Oncol 79(2):179–184

Article  PubMed  Google Scholar 

Li YX, Liu QF, Wang WH et al (2011) Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy. Cancer 117(22):5203–5211

Article  PubMed  Google Scholar 

Koom WS, Chung EJ, Yang WI et al (2004) Angiocentric T‑cell and NK/T-cell lymphomas: radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys 59(4):1127–1137

Article  PubMed  Google Scholar 

Wang L, Bi XW, Xia ZJ et al (2016) Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy. Onco Targets Ther 9:5875–5881

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li YY, Lin HQ, Zhang LL et al (2017) Intensity-modulated radiotherapy has superior outcomes to three-dimensional conformal radiotherapy in patients with stage IE-IIE extranodal nasal-type natural killer/T-cell lymphoma. Oncotarget 8(36):60504–60513

Article  PubMed  PubMed Central  Google Scholar 

Wang H, Li YX, Wang WH et al (2012) Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma. Int J Radiat Oncol Biol Phys 82(3):1115–1121

Article  PubMed  Google Scholar 

Tomita N, Kodaira T, Tachibana H et al (2009) A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer/T-cell lymphoma. Br J Radiol 82(981):756–763

Article  PubMed  Google Scholar